Auris is working on the development of a new drug for external use against acute otitis media (ear infection). The business idea involves using a well known bacteriacidal chemical which is put in specially designed ear-plugs that are then placed in the external ear. The treatment is supposed to replace the traditional antibiotic treatment. Side-effects often follow antibiotic treatment and therefore there is an acute need for other treatment. Clinical research has been conducted where the drug was tested on children with acute otitis media (ear infection). Today the company is seeking collaboraters for the ongoing development and preparation for the marketing of the drug.


Page style: